The clinical assessment of rheumatoid arthritis using FDG-PET

The clinical assessment of rheumatoid arthritis using FDG-PET - The assessment of rheumatoid arthritis using FDG-PET

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006061

Enrollment

Registered

2011-07-28

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

DMARDs and Biologics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ACR1987 criteria RA patients. Informed consent is obtained from each patietns .

Exclusion criteria

Exclusion criteria: RA patietns who can not be treated by biologics. RA patietns who has overlap collagen diseases.

Design outcomes

Primary

Measure	Time frame
a correlation between the difference of SUV and improvement of clinical findings in RA patients	—

Countries

Japan

Contacts

Public ContactKoichi Okamura

Gunma University Hospital Department of Orthopaedic Surgery

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026